tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

SCPH Stock Latest News

scPharmaceuticals Earnings Call Highlights Growth and Expansion
Company AnnouncementsscPharmaceuticals Earnings Call Highlights Growth and Expansion
20d ago
SCPH
scPharmaceuticals Reports Strong Q1 2025 Growth
PremiumCompany Announcements
scPharmaceuticals Reports Strong Q1 2025 Growth
21d ago
SCPH
Promising Growth Outlook for scPharmaceuticals Driven by Furoscix Expansion and Strong Market Demand
PremiumRatings
Promising Growth Outlook for scPharmaceuticals Driven by Furoscix Expansion and Strong Market Demand
21d ago
SCPH
scPharmaceuticals reports Q1 EPS (37c), consensus (28c)
PremiumThe Fly
scPharmaceuticals reports Q1 EPS (37c), consensus (28c)
21d ago
SCPH
scPharmaceuticals’ Earnings Call Highlights Growth and Challenges
PremiumCompany Announcements
scPharmaceuticals’ Earnings Call Highlights Growth and Challenges
2M ago
SCPH
Optimistic Buy Rating for scPharmaceuticals Amid Strong Q4 Results and Promising Developments
PremiumRatingsOptimistic Buy Rating for scPharmaceuticals Amid Strong Q4 Results and Promising Developments
3M ago
SCPH
scPharmaceuticals price target lowered to $12 from $20 at Maxim
Premium
The Fly
scPharmaceuticals price target lowered to $12 from $20 at Maxim
3M ago
SCPH
Promising Growth Trajectory and Strategic Expansion Drive Buy Rating for scPharmaceuticals
Premium
Ratings
Promising Growth Trajectory and Strategic Expansion Drive Buy Rating for scPharmaceuticals
3M ago
SCPH
Strong Growth Prospects for scPharmaceuticals: Buy Rating Justified by Furoscix Success and Strategic Expansion
PremiumRatings
Strong Growth Prospects for scPharmaceuticals: Buy Rating Justified by Furoscix Success and Strategic Expansion
3M ago
SCPH
scPharmaceuticals Reports Strong Revenue Growth in 2024
PremiumCompany Announcements
scPharmaceuticals Reports Strong Revenue Growth in 2024
3M ago
SCPH
scPharmaceuticals reports Q 4EPS (35c), consensus (39c)
PremiumThe Fly
scPharmaceuticals reports Q 4EPS (35c), consensus (39c)
3M ago
SCPH
Options Volatility and Implied Earnings Moves Today, March 19, 2025
PremiumMarket News
Options Volatility and Implied Earnings Moves Today, March 19, 2025
3M ago
KC
YY
Expanding Horizons: scPharmaceuticals’ Furoscix Gains FDA Approval for CKD, Broadening Market Potential
PremiumRatingsExpanding Horizons: scPharmaceuticals’ Furoscix Gains FDA Approval for CKD, Broadening Market Potential
3M ago
SCPH
Strategic Market Expansion and Strong Sales Foundation Drive Buy Rating for scPharmaceuticals
Premium
Ratings
Strategic Market Expansion and Strong Sales Foundation Drive Buy Rating for scPharmaceuticals
3M ago
SCPH
scPharmaceuticals announces FDA approval of Furoscix indication expansion
Premium
The Fly
scPharmaceuticals announces FDA approval of Furoscix indication expansion
3M ago
SCPH
Promising Outlook for scPharmaceuticals: Buy Rating Justified by Strong Demand and Strategic Initiatives
PremiumRatings
Promising Outlook for scPharmaceuticals: Buy Rating Justified by Strong Demand and Strategic Initiatives
3M ago
SCPH
scPharmaceuticals reports preliminary Q4 FUROSCIX revenue $12M-$12.3M
PremiumThe Fly
scPharmaceuticals reports preliminary Q4 FUROSCIX revenue $12M-$12.3M
5M ago
SCPH
scPharmaceuticals price target lowered to $12 from $16 at Craig-Hallum
PremiumThe Fly
scPharmaceuticals price target lowered to $12 from $16 at Craig-Hallum
7M ago
SCPH
scPharmaceuticals Reports Strong Growth in Q3 2024
PremiumCompany Announcements
scPharmaceuticals Reports Strong Growth in Q3 2024
7M ago
SCPH
scPharmaceuticals reports Q3 EPS (41c), consensus (30c)
PremiumThe FlyscPharmaceuticals reports Q3 EPS (41c), consensus (30c)
7M ago
SCPH
SCPH Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
SCPH Earnings Report this Week: Is It a Buy, Ahead of Earnings?
7M ago
SCPH
scPharmaceuticals to host KOL webinar on FUROSCIX use
Premium
The Fly
scPharmaceuticals to host KOL webinar on FUROSCIX use
8M ago
SCPH

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >